Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 130

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 7
Chunk 130
---
 insurance statutes and other regulatory requirements, while preserving our asset base. Our investments are generally available-for-sale to meet liquidity and other needs. Our subsidiaries pay out excess capital annually in the form of dividends to their respective parent companies for general corporate use, as permitted by applicable regulations.

The availability of financing in the form of debt or equity is influenced by many factors, including our profitability, operating cash flows, debt levels, debt ratings, contractual restrictions, regulatory requirements and market conditions. The securities and credit markets have in the past experienced higher than normal volatility. Interest rates on fixed debt income securities have increased since the beginning of 2022, which may increase our borrowing costs if we elect to issue debt. During recent years, the federal government and various governmental agencies have taken a number of steps to strengthen the regulation of the financial services market. In addition, governments around the world have developed their own plans to provide stability and security in the credit markets and to ensure adequate capital in certain financial institutions. 

A summary of our major sources and uses of cash and cash equivalents for the years ended December 31, 2024, 2023 and 2022 is as follows: Years Ended December 31$ Change 2024202320222024 vs. 20232023 vs. 2022Sources of Cash:Net cash provided by operating activities$5,808 $8,061 $8,399 $(2,253)$(338)Proceeds from sales, maturities, calls and redemptions of investments, net of purchases586 — — 586 — Issuances of short- and long-term debt, net of repayments6,200 626 862 5,574 (236)Issuances of common stock under employee stock plans221 152 182 69 (30)Other sources of cash, net— — 762 — (762)Total sources of cash12,815 8,839 10,205 3,976 (1,366)Uses of Cash:Purchases of investments, net of proceeds from sales, maturities, calls and redemptions— (2,700)(2,338)2,700 (362)Repurchase and retirement of common stock(2,900)(2,676)(2,316)(224)(360)Purchases of subsidiaries, net of cash acquired(4,809)(1,552)(649)(3,257)(903)Purchases of property